These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


577 related items for PubMed ID: 8062938

  • 21. Controlled Ovarian Stimulation Using Medroxyprogesterone Acetate and hMG in Patients With Polycystic Ovary Syndrome Treated for IVF: A Double-Blind Randomized Crossover Clinical Trial.
    Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y.
    Medicine (Baltimore); 2016 Mar; 95(9):e2939. PubMed ID: 26945402
    [Abstract] [Full Text] [Related]

  • 22. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA, Gómez-Palomares JL, Ricciarelli E, Hernández ER.
    Fertil Steril; 2010 Mar 01; 93(4):1215-9. PubMed ID: 19200978
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S, Paradisi R, Fabbri R, Porcu E, Orsini LF, Flamigni C.
    Int J Fertil; 1987 Mar 01; 32(1):66-70. PubMed ID: 2880819
    [Abstract] [Full Text] [Related]

  • 25. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation.
    Lee KL, Couchman GM, Walmer DK.
    J Assist Reprod Genet; 2005 Jan 01; 22(1):37-40. PubMed ID: 15807221
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC, Hop WC, de Jong FH, van Dessel TJ, Fauser BC.
    Fertil Steril; 1995 Dec 01; 64(6):1081-7. PubMed ID: 7589656
    [Abstract] [Full Text] [Related]

  • 28. Luteal phase estradiol and pregnancy outcome in gonadotropin releasing hormone agonist/human menopausal gonadotropin-treated gamete intrafallopian transfer cycles.
    Molo MW, Rawlins RG, Binor Z, Kelly M, Radwanska E.
    J Reprod Med; 1995 Jun 01; 40(6):418-22. PubMed ID: 7650652
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY.
    Hum Reprod; 2013 Sep 01; 28(9):2511-21. PubMed ID: 23753114
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients.
    Martazanova B, Mishieva N, Vedikhina I, Kirillova A, Korneeva I, Ivanets T, Abubakirov A, Sukhikh GT.
    Front Endocrinol (Lausanne); 2022 Sep 01; 13():834627. PubMed ID: 36046787
    [Abstract] [Full Text] [Related]

  • 33. A study on follicle stimulation and ovulation induction in polycystic ovary syndrome (PCOS).
    Ito T, Michioka T, Kobayashi M, Narimatsu A, Yamashita S, Matsuzaki H, Kuramoto T, Numa F, Yakabe A.
    Horm Res; 1990 Sep 01; 33 Suppl 2():32-4. PubMed ID: 2128879
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
    Agrawal R, Conway GS, Engmann L, Bekir JS, Jacobs HS.
    Gynecol Endocrinol; 1998 Feb 01; 12(1):9-15. PubMed ID: 9526704
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ, Li XM, Chen XM, Zhang L.
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep 01; 122(1):79-84. PubMed ID: 16154042
    [Abstract] [Full Text] [Related]

  • 38. The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
    Wang CF, Gemzell C.
    Fertil Steril; 1980 May 01; 33(5):479-86. PubMed ID: 6768596
    [Abstract] [Full Text] [Related]

  • 39. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction.
    Araujo E, Bernardini L, Frederick JL, Asch RH, Balmaceda JP.
    J Assist Reprod Genet; 1994 Feb 01; 11(2):74-8. PubMed ID: 7819706
    [Abstract] [Full Text] [Related]

  • 40. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL, Maslow BS, Kaye LA, Griffin DW, DiLuigi AJ, Schmidt DW, Grow DR, Nulsen JC, Benadiva CA.
    J Ovarian Res; 2019 Jan 26; 12(1):8. PubMed ID: 30684970
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.